Fluocinonide NDC 70710-1284

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1284Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1284Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1284-3	70710128403	60 mL in 1 BOTTLE (70710-1284-3)Marketed from Nov 1, 2018
70710-1284-8	70710128408	20 mL in 1 BOTTLE (70710-1284-8)Marketed from Nov 1, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208948
Marketing start: Nov 1, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70710-1284_bd0eaa0d-0a5b-48a2-bc7e-78b8bde33962SPL ID bd0eaa0d-0a5b-48a2-bc7e-78b8bde33962SPL set ID 73315c87-4e55-41ea-883b-23d504c1b10dRxCUI 310364UNII 2W4A77YPANUPC 0370710128432
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710128403 followed by a unit qualifier and the quantity

Package 70710-1284-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 4, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluocinonide topical solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208948

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208948
Product	Strength	Form · route	Labeler	Product NDC
Fluocinonide	Fluocinonide .5 mg/mL	SolutionTopical	Zydus Lifesciences Limited	70771-1375